Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UQ5B
|
|||
| Former ID |
DIB001823
|
|||
| Drug Name |
GSK-1437173A
|
|||
| Synonyms |
Adult herpes zoster vaccine (shingles prophylaxis), GlaxoSmithKline; Adult varicella zoster vaccine (attenuated recombinant viralvaccine), GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 3 | [1] | |
| Company |
Glaxosmithkline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01767467) Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With BloodCancers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.